首页> 外国专利> Compounds, preparation process, and uses thereof used for interrupting reuptake of 5-hydroxytryptamine and norepinephrine or treating diseases such as depression et al.

Compounds, preparation process, and uses thereof used for interrupting reuptake of 5-hydroxytryptamine and norepinephrine or treating diseases such as depression et al.

机译:用于中断5-羟基色胺和去甲肾上腺素的再摄取或治疗疾病例如抑郁症的化合物,制备方法及其用途。

摘要

Compounds of the general formula (I), optical isomers, pharmaceutically acceptable salts,preparation process and uses thereof in which R1, R2, R3 and R4 are as defined inspecification are disclosed. Such compounds can be optical isomers or racemic mixturesand can be metabolically transformated into 1-[2-dimethylamine-1-(4-hydroxyphenyl)-ethyl]cyclohexanol withnew pharmaceutically active in vivo after administration, which can be usedfor treating diseases associated central nervous system such as depression etal. by interrupting reuptake of 5-hydroxytryptamine (5-HT ) and norepinephrine (NA) .
机译:通式(I)的化合物,旋光异构体,可药用盐,制备方法及其用途,其中R1,R2,R3和R4的定义如说明书被公开。这样的化合物可以是旋光异构体或外消旋混合物可以被代谢成1- [2-二甲基胺-1-(4-羟苯基)-乙基]环己醇给药后在体内具有新的药物活性,可用于用于治疗与中枢神经系统有关的疾病,例如抑郁症等等通过中断5-羟色胺(5-HT)和去甲肾上腺素(NA)。

著录项

  • 公开/公告号AU2006257558B2

    专利类型

  • 公开/公告日2012-01-12

    原文格式PDF

  • 申请/专利权人 YOUXIN LI;SHANDONG LUYE PHARMACEUTICAL CO. LTD.;

    申请/专利号AU20060257558

  • 发明设计人 ZHANG LUPING;

    申请日2006-06-16

  • 分类号C07C215/42;A61K31/222;A61P25;C07C217/60;C07C219/24;

  • 国家 AU

  • 入库时间 2022-08-21 17:19:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号